B.Riley/FBR Upgrades Adamis Pharmaceuticals (ADMP) to Neutral
Tweet Send to a Friend
B.Riley/FBR analyst Andrew D\'Silva upgraded Adamis Pharmaceuticals (NASDAQ: ADMP) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
